Results

Cansino Biologics Inc.

04/08/2021 | Press release | Distributed by Public on 04/07/2021 22:00

INSIDE INFORMATION RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR) APPROVED FOR EMERGENCY USE IN CHILE